Correction press release: Vitrolife´s CEO has purchased shares

Rhea-AI Summary

Vitrolife's CEO Thomas Axelsson has acquired 12,000 shares valued at 2,124,000 SEK, increasing his total holdings to 25,000 shares. This significant purchase reflects confidence in the company's future performance. The transaction will comply with regulations outlined by the Swedish Financial Supervisory Authority and was disclosed on October 28, 2022. The information is part of Vitrolife's obligations under the EU Market Abuse Regulation.

Positive

• CEO Thomas Axelsson's purchase signifies confidence in the company's stock performance.
• Acquisition of 12,000 shares valued at 2,124,000 SEK indicates strong investment backing.

Negative

• None.

GOTHENBURG, Sweden, Oct. 28, 2022 /PRNewswire/ -- Vitrolife's CEO Thomas Axelsson has today acquired 12,000 shares worth 2,124,000 SEK. The total holdings of shares amount to 25,000.

The transaction will be reported to The Swedish Financial Supervisory Authority (Finansinspektionen) according to current regulations.

Gothenburg, October 28, 2022
VITROLIFE AB (publ)
Thomas Axelsson, CEO

Contact persons:
Thomas Axelsson, CEO, phone: +46 31 721 80 01
Patrik Tolf, CFO, phone: +46 31 766 90 21

This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 10.55 am CET on October 28, 2022.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

The following files are available for download:

https://mb.cision.com/Main/1031/3657484/1645421.pdf

Correction press release: Vitrolife´s CEO has purchased shares

View original content:https://www.prnewswire.com/news-releases/correction-press-release-vitrolifes-ceo-has-purchased-shares-301662185.html

SOURCE Vitrolife AB (publ)

FAQ

What shares did Vitrolife's CEO Thomas Axelsson purchase?

Thomas Axelsson purchased 12,000 shares of Vitrolife valued at 2,124,000 SEK.

When did the CEO of Vitrolife make the share purchase?

The share purchase was made on October 28, 2022.

How many total shares does CEO Thomas Axelsson own after the purchase?

After the purchase, Thomas Axelsson owns a total of 25,000 shares.

Is the share purchase compliant with regulations?

Yes, the transaction will be reported to the Swedish Financial Supervisory Authority as per regulations.

What is the value of the shares purchased by Vitrolife's CEO?

The value of the shares purchased is 2,124,000 SEK.